Labiotech.eu

cancer biotech killers deadliest oncology therapies immunooncology

News and Trends 19 Jan 2016

Top 8 Deadliest Cancers and their Potential Cures

With more than 200 types of cancer, the possibility of developing a Universal Cure is in reality, a myth. However, the fight against the World’s Deadliest Cancers is far from being lost…and there lies hope in the Biotech Industry. Simply by having a quick look through our articles, we can easily confirm that cancer is […]

January 19, 2016 - 7 minutesmins - By Dani Bancroft

macular degeneration xbrane helvetic xlucane biosimilar lucentis blindness iran

News and Trends 18 Jan 2016

Where there be Patent-Free Markets: Swiss-Swedish Biosimilar for Blindess Reaches Iran

Helvetic BioPharma (Switzerland) estimates that 70,000 people suffer from age-related macular degeneration in Iran, the leading cause of blindness. This deal with Xbrane in Stockholm (Sweden) will debut a biosimilar therapy that could really tackle this problem. Xbrane itself is a Swedish biopharma with links to Italy (after an acquisition of the Italian Primm Pharma […]

January 18, 2016 - 2 minutesmins - By Dani Bancroft

$jp morgan biotech conference san fracisco morphosys$

News and Trends 18 Jan 2016

Inside Biotech’s Most Secretive Elite Conference: MorphoSys Talks on Investor Speed Dating in California

MorphoSys is the Biggest Biotech in Germany, and second biggest in Europe – so it is no wonder they were selected for access to the exclusive J.P.Morgan Conference in San-Francisco last week. Here, the MorphoSys team, which included Claudia Gutjahr-Löser and the CEO Simon Moroney, give you a sneak-insiders look into one of the most elite Biotech […]

January 18, 2016 - 4 minutesmins - By Philip Hemme

News and Trends 16 Jan 2016

What happened this week? 10 Hot EU Biotechs, J.P. Morgan and a Surprise

Monday: How about the $100M Holy ‘GRAIL’ in Cancer Diagnostics? A Universal Test Start-up Faces German Competition Tuesday: 10 Hot European Biotechs to watch in 2016 Wednesday: UK Biotech starts 2016 by signing a (Massive?) Immuno-Oncology Deal with AbbVie Thursday: The Biotech World is Buzzing: J.P. Morgan’s 2016 Phenomenon Kicks off this Week! Friday: Faces […]

January 16, 2016 - 1 minutemin - By Philip Hemme

eduardo kac bioart alba gfp genesis synbio cypher edunia transArt

News and Trends 15 Jan 2016

Faces of BioArt: Eduardo Kac and His Transgenic Organisms

Last week I talked about my experience meeting Susanna Hertrich at the Art Laboratory Berlin, and now I move to Eduardo Kac, who actually coined the term ‘BioArt’. As a US-Brazilian from Rio, Eduardo has developed a global reputation as a ‘Transgenic Artist‘. One of Eduardo Kac‘s most famous pieces, ‘Genesis‘ (1999), was a transgenic […]

January 15, 2016 - 2 minutesmins - By Dani Bancroft

gals german life sciences startup accelerator sonormed tinnitracks ayoxxa personal medsystems pepperprint

News and Trends 15 Jan 2016

The German Accelerator in Boston’s 4 Rising Biotech Stars

During the 34th JP Morgan Healthcare Conference in San Francisco, the German Accelerator Life Sciences (GALS) announced the first four companies to participate in its Cambridge-based program. Germany has a long-standing reputation for life science innovation. However, most pharmaceutical and biotech companies are now headquartered in the US, and significantly more digital health solutions are […]

January 15, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 15 Jan 2016

Biotech of the week: Kiadis Pharma, Immuno-therapy made in Amsterdam

This week we say ‘auf Wiedersehen’ to Germany and head West to the Netherlands and it’s capital city, Amsterdam. This city really does have it all, whether you’re looking for history, architecture or something more indulgent… it is also the location of our biotech of the week: Kiadis Pharma City: Amsterdam, Netherlands Founded: 1997 Employees: 23 (as of 12/2015) […]

January 15, 2016 - 2 minutesmins - By Philip Hemme

jp morgan biotech san francisco california 2016

News and Trends 14 Jan 2016

The Biotech World is Buzzing: J.P. Morgan’s 2016 Phenomenon Kicks off this Week!

Imagine a conference where all the Biotech CEOs and investors of the World come together…all the major players in this Industry, under one roof. That’s basically what the J.P.Morgan Conference is about. Organized by the banking firm of the same name, it is the 34th edition this year. And with age, comes exclusivity: The J.P. […]

January 14, 2016 - 4 minutesmins - By Philip Hemme

glycomar astaxanthin polysacchiride prasinotech mmicroa microalgae biotech algae

News and Trends 14 Jan 2016

World First: Scotland and Norway have Founded a Unique Oceanic Algae Plant

GlycoMar (Scotland) and MicroA (Norway) are Algae specialists in the Biotech industry which have now funded a joint Venture, Prasinotech, which is the first in the world to refine the production of polysaccharides from microalgae. GlycoMar is based at the European Centre for Marine Biotechnology, near Oban (Scotland), and is a specialist biotech developing new […]

January 14, 2016 - 3 minutesmins - By Dani Bancroft

avian influenza flu bird pandemic nature host imperial

News and Trends 14 Jan 2016

Angry birds: How does Avian Influenza Virus infect Human cells?

What does the bird flu virus have to change in order to takeover the human cell machinery? For the first time, researchers from Imperial College London have identified the pathway that allows Avian flu virus to hop from bird’s to mammalian cells. Influenza pandemics aren’t easy to predict: outbreaks occur when zoonotic influenza viruses suddenly […]

January 14, 2016 - 3 minutesmins - By Lourdes Riquelme

HIV abivax Alexey Kashpersky abx464 trial antiviral

News and Trends 13 Jan 2016

A Phase II HIV Antiviral from France Has Promising Results

Abivax in Paris (France) has released its phase IIa clinical results for an antiviral therapy for patients with HIV infection, which could potentially take a corner in an annual $18Bn market. HIV and AIDs have a long-standing history (the quick – yet fascinating story of which can be read here), and since 1983 (when the […]

January 13, 2016 - 3 minutesmins - By Dani Bancroft

f star fcab immunoncology abbvie babraham cancer

News and Trends 13 Jan 2016

UK Biotech starts 2016 by signing a (Massive?) Immuno-Oncology Deal with AbbVie

This year has started with a rush of deals for many Biotechs. F-Star another such company, now signing up for an Immuno-Oncology deal with AbbVie using Bispecific Antibodies. Financial terms were not disclosed but in regards to the hype of the Immuno-Oncology field, it could be pretty high. F-Star is a Cambridge company based at the Babraham […]

January 13, 2016 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Top 8 Deadliest Cancers and their Potential Cures

Where there be Patent-Free Markets: Swiss-Swedish Biosimilar for Blindess Reaches Iran

Inside Biotech’s Most Secretive Elite Conference: MorphoSys Talks on Investor Speed Dating in California

What happened this week? 10 Hot EU Biotechs, J.P. Morgan and a Surprise

Faces of BioArt: Eduardo Kac and His Transgenic Organisms

The German Accelerator in Boston’s 4 Rising Biotech Stars

Biotech of the week: Kiadis Pharma, Immuno-therapy made in Amsterdam

The Biotech World is Buzzing: J.P. Morgan’s 2016 Phenomenon Kicks off this Week!

World First: Scotland and Norway have Founded a Unique Oceanic Algae Plant

Angry birds: How does Avian Influenza Virus infect Human cells?

A Phase II HIV Antiviral from France Has Promising Results

UK Biotech starts 2016 by signing a (Massive?) Immuno-Oncology Deal with AbbVie

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!